Clinical Trials Browser

Unknown × OTHER × Primary Myelofibrosis × Clear all

NCT04888741 2023-09-28

MoTD

Phase 2 Unknown

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT02530619 2021-05-26

Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

Phase NA Unknown

26 enrolled 10 charts

MyeloidOther hematologic neoplasm

Leukemia, Megakaryoblastic, Acute, Primary Myelofibrosis

NCT01298934 2015-03-06

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Phase 1/2 Unknown

Polycythemia Vera, Primary Myelofibrosis

NCT00668421 2014-11-26

CEP-701 (Lestaurtinib) in Myelofibrosis

Phase 1/2 Unknown

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT01816022 2013-03-21

Myeloproliferative Neoplasms and Bone Structure

Osteoporosis, Polycythemia Vera, Thrombocythemia, Essential, Fractures, Bone, Primary Myelofibrosis